Search

Recent Updates to Formulary

12/10/2018:

Midostaurin - Added to formulary as Red and link to NICE TA523

Brentuximab - Added link to NICE TA524

Atezolizumab - Added link to NICE TA525

Arsenic trioxide - Added link to NICE TA526

Interferon Beta - Added link to NICE TA527

Glatiramer - Added link to NICE TA527

Ulipristal - Amended from Not Approved to Green+ (for pre-operative treatment of uterine fibroids only)

01/09/2018

Dupilumab - Added to formulary as Red and link to NICE TA534

16/08/2018:

Avelumab - Added to formulary as Red and link to NICE TA517

Pembrolizumab - Added link to NICE TA519

Tocilizumab - Added link to NICE TA518

Atezolizumab - Added to formulary as Red and link to NICE TA520

Guselkumab - Added to formulary as Red and link to NICE TA521

30/07/2018:

Fentanyl Immediate Release Preparations - Text amended to include palliative care exemptions

13/06/2018:

Pertuzumab - Added link to NICE TA509

Daratumumab - Added to formulary as Red and link to NICE TA510

Brodalumab - Added to formulary as Red and link to NICE TA511

Tivozanib - Added to formulary as Red and link to NICE TA512

Obinutuzumab - Added link to NICE TA513

Regorafenib - Added link to NICE TA514

Eribulin - Added link to NICE TA515

Cabozantinib - Added link to NICE TA516

Safinamide - RAG status changed to Green+ from Red

Eluxadoline - Added to formulary as Green+ and link to NICE TA471

22/05/2018:

Ulipristal (Esmya) - Changed from Green+/Red to Not Approved as per CAS alert

23/04/2018:

Goserelin - Changed from Green+ to Amber

16/04/2018:

"Do not prescribe" items from "Tees Do Not Prescribe/Grey List" document added as Not Approved:

Hydrocortisone sodium phosphate (Efcortesol), Ibandronic acid, Prednisolone EC, Yohimbine, Bethanechol, Calcium 500mg/colecalciferol 200units, Cod liver oil capsules, Gamolenic acid/Starflower oil, Iron MR preparations, Spatone, Vitamin B Compound, Methocarbamol, Naproxen/esomeprazole, Synovial fluid injections, Idoxuridine in Dimethyl Sulfoxide, Lanolin cream, Molludab Topical Solution, Silk Garments (Dermasilk, Dreamsilk, Skinnies Silk), Bio oil, Eyelid cleaning products for blepharitis, Infantile colic products

12/04/2018:

Lenvatinib - Added to formulary as Red and link to NICE

Glecaprevir/pibrentasvir - Added to formulary as Red and link to NICE

Sofosbuvir/velpatasvir/voxilaprevir - Added to formulary as Red and link to NICE

Opicapone - Added to formulary as Green+

Lesinurad - Added to formulary as Not Approved and link to NICE

Ixazomib - Added to formulary as Red and link to NICE

Ceritinib - Added to formulary as Red and link to NICE

28/03/2018:

"Do not prescribe" items from "Tees Do Not Prescribe/Grey List" document added as Not Approved:

Kaolin, Kaolin & Morphine, Liquid Paraffin Oral Emulsion, Liquid Paraffin with Magnesium Hydroxide, Co-flumactone, Etamasylate, Guanethidine, Moxisylyte, Oxerutins, Simvastatin/Ezetimibe, Trandolapril/Verapamil, Ciclesonide, Levocetirizine, Chloral hydrate, Clomipramine SR, Co-careldopa Intestinal Gel, Aspirin/Codeine, Ergotamine, e-Voke electronic inhaler, Flurazepam, Isocarboxazid, Meprobamate, Pentazocine, Tranylcypromine, Trimipramine, Ketoconazole (oral preparations), Alendronate plus Vitamin D,

Previously "Grey List" items changed to Not Approved:

Aliskiren, Doxazosin MR, Perindopril arginine, Cough and Cold Remedies, Dosulepin, Oxycodone/Naloxone, Paracetamol/Tramadol, Amorolfine, Other Antimalarials, Minocycline (for acne)

"Grey List" items added to formulary:

Norethisterone, Medroxyprogesterone

07/03/2018:

Lanthanum - Added to formulary as Red (renal dialysis) and Green+

Sevelamer - Added to formulary as Red (renal dialysis) and Green+

26/02/2018:

Desmopressin (Noqdirna) - Added to formulary as Amber

Methenamine - Added to formulary as Green

Fiasp (Insulin Aspart) - Added to formulary as Green+

Roflumilast - Added to formulary as Green+ with link to NICE TA461

12/02/2018:

Ulipristal Acetate (Esmya) - Added link to CAS Alert February 2018

Ibrutinib - Added link to NICE TA491

Nivolumab - Added link to NICE TAs 483, 484 and 490

Vismodegib - Added to formulary as Not Approved and link to NICE TA489

Regorafenib - Added to formulary as Red and link to NICE TA488

Venetoclax - Added to formulary as Red and link to NICE TA487

Sarilumab - Added to formulary as Red and link to NICE TA485

Basiliximab - Added link to NICE TAs 481 and 482. Removed old TA85 and TA99 links

Tacrolimus - Added link to NICE TAs 481 and 482

Mycophenolate mofetil - Added link to NICE TAs 481 and 482

Everolimus - Added link to NICE TAs 481 and 482

Tofacitinib - Added to formulary as Red and link to NICE TA480

Reslizumab - Added to formulary as Red and link to NICE TA479

Brentuximab - Added link to NICE TA478

19/01/2018:

Alimemazine (Unclassified) - Added to formulary

21/12/2017:

Brivaracetam (Green +) and Freestyle Libre (Red) - Added to formulary

19/12/2017:

Eluxadoline (Not Approved) - Removed from formulary

28/11/2017:

Octreotide (Palliative Care) - Updated with an Amber entry to reflect shared care guideline for this indication